Michael Steurer

4.5k total citations · 1 hit paper
103 papers, 2.7k citations indexed

About

Michael Steurer is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Michael Steurer has authored 103 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 32 papers in Hematology and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Michael Steurer's work include Chronic Lymphocytic Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (27 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). Michael Steurer is often cited by papers focused on Chronic Lymphocytic Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (27 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers). Michael Steurer collaborates with scholars based in Austria, Germany and Switzerland. Michael Steurer's co-authors include Eberhard Gunsilius, Dominik Wolf‎, Guenther Gastl, Günther Gastl, Adam L. Martin, Robert S. Aronstam, Richard Greil, Gerold Untergasser, Albert Amberger and Johann Kern and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael Steurer

98 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increase of regulatory T cells in the peripheral blood of cancer patients.

2003 534 citations Michael Steurer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Steurer Austria	27	885	799	745	663	615	103	2.7k
Lei Gao China	25	711 0.8×	562 0.7×	986 1.3×	467 0.7×	667 1.1×	170	2.4k
Chiaki Nakaseko Japan	31	776 0.9×	682 0.9×	675 0.9×	765 1.2×	1.7k 2.7×	166	3.5k
Gian Matteo Rigolin Italy	30	904 1.0×	693 0.9×	710 1.0×	1.1k 1.7×	831 1.4×	117	2.8k
June‐Won Cheong South Korea	29	1.0k 1.2×	326 0.4×	625 0.8×	581 0.9×	994 1.6×	182	2.7k
Maria Christina Cox Italy	30	850 1.0×	430 0.5×	842 1.1×	516 0.8×	1.2k 2.0×	111	2.8k
Alessandro Isidori Italy	26	626 0.7×	743 0.9×	769 1.0×	473 0.7×	1.1k 1.9×	89	2.4k
Matthias Mayerhofer Austria	32	1.3k 1.4×	1.3k 1.6×	446 0.6×	820 1.2×	1.1k 1.8×	75	3.2k
George E. Georges United States	29	597 0.7×	777 1.0×	585 0.8×	641 1.0×	1.7k 2.7×	106	3.1k
A Tobler Switzerland	26	1.0k 1.1×	420 0.5×	806 1.1×	394 0.6×	550 0.9×	70	2.3k
Kazimierz Kuliczkowski Poland	29	1.1k 1.3×	978 1.2×	1.2k 1.7×	1.1k 1.7×	1.2k 2.0×	202	3.5k

Countries citing papers authored by Michael Steurer

Since Specialization

Citations

This map shows the geographic impact of Michael Steurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Steurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Steurer more than expected).

Fields of papers citing papers by Michael Steurer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Steurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Steurer. The network helps show where Michael Steurer may publish in the future.

Co-authorship network of co-authors of Michael Steurer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Steurer. A scholar is included among the top collaborators of Michael Steurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Steurer. Michael Steurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kofler, Barbara, et al.. (2021). ALADA Dose Optimization in the Computed Tomography of the Temporal Bone: The Diagnostic Potential of Different Low-Dose CT Protocols. Diagnostics. 11(10). 1894–1894. 9 indexed citations

Plaikner, Michaela, Christian Kremser, Heinz Zoller, et al.. (2020). Evaluation of liver iron overload with R2* relaxometry with versus without fat suppression: both are clinically accurate but there are differences. European Radiology. 30(11). 5826–5833. 5 indexed citations

Henninger, Benjamin, Michael Steurer, Michaela Plaikner, et al.. (2020). Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas. European Radiology. 30(11). 6014–6021. 5 indexed citations

Henninger, Benjamin, Esther Raithel, Christof Kranewitter, et al.. (2018). Evaluation of an accelerated 3D SPACE sequence with compressed sensing and free-stop scan mode for imaging of the knee. European Journal of Radiology. 102. 74–82. 7 indexed citations

Widmann, Gerlig, F. Waldenberger, Peter Schullian, et al.. (2017). Influence of Ultra-Low-Dose and Iterative Reconstructions on the Visualization of Orbital Soft Tissues on Maxillofacial CT. American Journal of Neuroradiology. 38(8). 1630–1635. 8 indexed citations

Feistritzer, Clemens, et al.. (2016). Successful immune tolerance induction using turoctocog alfa in an adult haemophilia A patient. Blood Coagulation & Fibrinolysis. 28(2). 181–184. 3 indexed citations

Martin, Adam L., Michael Steurer, & Robert S. Aronstam. (2015). Constitutive Activity among Orphan Class-A G Protein Coupled Receptors. PLoS ONE. 10(9). e0138463–e0138463. 119 indexed citations

Steurer, Michael, Lydia Scarfò, Marco Montillo, et al.. (2014). INTERIM RESULTS FROM A PHASE IIA STUDY OF THE ANTI-CXCL12 SPIEGELMER OLAPTESED PEGOL (NOX-A12) IN COMBINATION WITH BENDAMUSTINE/RITUXIMAB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. Haematologica. 99. 59–59. 2 indexed citations

Pauli, Franziska Di, Thomas Berger, Alois Walder, et al.. (2014). Progressive multifocal leukoencephalopathy complicating untreated chronic lymphatic leukemia: Case report and review of the literature. Journal of Clinical Virology. 60(4). 424–427. 9 indexed citations

10.

Fiegl, Michael, Reinhard Stauder, Michael Steurer, et al.. (2013). Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology. 93(2). 267–277. 12 indexed citations

11.

Finkenstedt, Armin, Claudia Auer, Bernhard Glodny, et al.. (2013). Patatin-Like Phospholipase Domain-Containing Protein 3 rs738409-G in Recipients of Liver Transplants Is a Risk Factor for Graft Steatosis. Clinical Gastroenterology and Hepatology. 11(12). 1667–1672. 75 indexed citations

12.

Bánki, Zoltán, G. Carl Huber, Asim Ejaz, et al.. (2013). Complement factor H-derived short consensus repeat 18-20 enhanced complement-dependent cytotoxicity of ofatumumab on chronic lymphocytic leukemia cells. Haematologica. 98(12). 1939–1947. 26 indexed citations

13.

Fong, Dominic, Gilbert Spizzo, Manfred Mitterer, et al.. (2012). Low Expression of Junctional Adhesion Molecule A Is Associated with Metastasis and Poor Survival in Pancreatic Cancer. Annals of Surgical Oncology. 19(13). 4330–4336. 37 indexed citations

14.

Fiegl, Michael, Florian Falkner, Michael Steurer, et al.. (2011). Successful alemtuzumab retreatment in progressive B-cell chronic lymphocytic leukemia: a multicenter survey in 30 patients. Annals of Hematology. 90(9). 1083–1091. 7 indexed citations

15.

Feenstra, Jelena D. Milosevic, Tiina Berg, Thorsten Klampfl, et al.. (2011). Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies. American Journal of Hematology. 87(3). 245–250. 80 indexed citations

16.

Petrides, Petro E., Heinz Gisslinger, Michael Steurer, et al.. (2009). Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation. Clinical Therapeutics. 31(2). 386–398. 9 indexed citations

17.

Fong, Dominic, Michael Steurer, Peter Obrist, et al.. (2006). Ep-CAM expression in pancreatic and ampullary carcinomas: frequency and prognostic relevance. Journal of Clinical Pathology. 61(1). 31–35. 99 indexed citations

18.

Steurer, Michael, Gilbert Spizzo, Manfred Mitterer, & Günther Gastl. (2004). Low-Dose Thalidomide for Multiple Myeloma: Interim Analysis of a Compassionate Use Program. Oncology Research and Treatment. 27(2). 150–154. 12 indexed citations

19.

Steurer, Michael, Gernot Fritsche, Alexandar Tzankov, et al.. (2004). Large‐vessel arteritis and myelodysplastic syndrome: report of two cases. European Journal Of Haematology. 73(2). 128–133. 21 indexed citations

20.

Steurer, Michael, et al.. (2004). Anagrelide for thrombocytosis in myeloproliferative disorders. Cancer. 101(10). 2239–2246. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact